SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAMME

被引:0
|
作者
Cohen, Stanley B. [1 ]
van Vollenhoven, Ronald [2 ]
Winthrop, Kevin [3 ]
Zerbini, Cristiano [4 ]
Tanaka, Yoshiya [5 ]
Bessette, Louis [6 ]
Zhang, Ying [7 ]
Khan, Nasser [7 ]
Hendrickson, Barbara [7 ]
Enejosa, Jeffrey V. [7 ]
Burmester, Gerd Rudiger [8 ]
机构
[1] Metroplex Clin Res Ctr, Dallas, TX USA
[2] ARC, Amsterdam Rheumatol & Immunol Ctr, Amsterdam, Netherlands
[3] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA
[4] Ctr Paulista Invest Clin, CEPIC, Sao Paulo, Brazil
[5] Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Japan
[6] Laval Univ, Fac Med, Quebec City, PQ, Canada
[7] AbbVie Inc, Waukegan Rd, N Chicago, IL USA
[8] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P209
引用
收藏
页码:96 / 96
页数:1
相关论文
共 50 条
  • [1] Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme
    Cohen, Stanley B.
    van Vollenhoven, Ronald F.
    Winthrop, Kevin L.
    Zerbini, Cristiano A. F.
    Tanaka, Yoshiya
    Bessette, Louis
    Zhang, Ying
    Khan, Nasser
    Hendrickson, Barbara
    Enejosa, Jeffrey, V
    Burmester, Gerd R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03) : 304 - 311
  • [2] SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM
    Cohen, Stanley B.
    van Vollenhoven, Ronald
    Winthrop, Kevin
    Zerbini, Cristiano
    Tanaka, Yoshiya
    Bessette, Louis
    Li Yihan
    Khan, Nasser
    Hendrickson, Barbara
    Burmester, Gerd Ruediger
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 357 - 357
  • [3] SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM
    Cohen, Stanley B.
    van Vollenhoven, Ronald
    Winthrop, Kevin
    Zerbini, Cristiano A. F.
    Tanaka, Yoshiya
    Bessette, Louis
    Zhang, Ying
    Khaff, Nasser
    Hendrickson, Barbara
    Enejosa, Jeffrey V.
    Burmesters, Gerd
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 10 - 10
  • [4] Safety Profile of Upadacitinib in Rheumatoid Arthritis: Integrated Analysis from the SELECT Phase 3 Clinical Program
    Cohen, Stanley
    van Vollenhoven, Ronald
    Winthrop, Kevin
    Zerbini, Cristiano A.
    Tanaka, Yoshiya
    Bessette, Louis
    Zhang, Ying
    Khan, Nasser
    Hendrickson, Barbara
    Enejosa, Jose Jeffrey
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [5] Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme (vol 80, pg 304, 2021)
    Cohen, S. B.
    van Vollenhoven, R. F.
    Winthrop, K. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (05)
  • [6] Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme
    Fleischmann, Roy
    Curtis, Jeffrey R.
    Charles-Schoeman, Christina
    Mysler, Eduardo
    Yamaoka, Kunihiro
    Richez, Christophe
    Palac, Hannah
    Dilley, Deanne
    Liu, Jianzhong
    Strengholt, Sander
    Burmester, Gerd
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (09) : 1130 - 1141
  • [7] Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program
    Kakehasi, Adriana Maria
    Radominski, Sebastiao Cezar
    Baravalle, Marcos Daniel
    Palazuelos, Fedra Consuelo Irazoque
    Garcia-Garcia, Conrado
    Arruda, Maysa Silva
    Curi, Marco
    Liu, John
    Qiao, Meihua
    Velez-Sanchez, Patricia
    Vargas, Juan Ignacio
    CLINICAL RHEUMATOLOGY, 2023, 42 (05) : 1249 - 1258
  • [8] Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program
    Adriana Maria Kakehasi
    Sebastião Cezar Radominski
    Marcos Daniel Baravalle
    Fedra Consuelo Irazoque Palazuelos
    Conrado Garcia-Garcia
    Maysa Silva Arruda
    Marco Curi
    John Liu
    Meihua Qiao
    Patricia Velez-Sanchez
    Juan Ignacio Vargas
    Clinical Rheumatology, 2023, 42 : 1249 - 1258
  • [9] MACE AND VTE ACROSS MULTIPLE UPADACITINIB STUDIES IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM
    Choy, Ernest
    McInnes, Lain B.
    Cush, John
    Aelion, Jacob
    Zhang, Ying
    Khan, Nasser
    Liu, Jianzhong
    Camp, Heidi S.
    Meerwein, Sebastian
    Rigby, William
    Cohen, Alexander T.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 11 - 11
  • [10] MACE and VTE Across Multiple Upadacitinib Studies in Rheumatoid Arthritis: Integrated Analysis from the SELECT Phase 3 Clinical Program
    Choy, Ernest
    McInnes, Iain
    Cush, John
    Aelion, Jacob
    Zhang, Ying
    Khan, Nasser
    Liu, Jianzhong
    Camp, Heidi
    Meerwein, Sebastian
    Rigby, William
    Cohen, Alexander
    ARTHRITIS & RHEUMATOLOGY, 2019, 71